no code implementations • 16 Jan 2024 • Zahra Tabatabaei, Adrián Colomer, Javier Oliver Moll, Valery Naranjo
The Breast-twins model achieves 70% of the F1score at the top first, which exceeds the other state-of-the-art methods at a higher amount of K such as 5 and 400.
2 code implementations • 11 Jan 2024 • Rocío del Amor, Julio Silva-Rodríguez, Adrián Colomer, Valery Naranjo
The development of computer vision solutions for gigapixel images in digital pathology is hampered by significant computational limitations due to the large size of whole slide images.
no code implementations • Nature 2023 • Andrés Mosquera-Zamudio, Laëtitia Launet, Rocío del Amor, Anaïs Moscardó, Adrián Colomer, Valery Naranjo & Carlos Monteagudo
Spitzoid tumors (ST) are a group of melanocytic tumors of high diagnostic complexity.
no code implementations • 5 May 2023 • Zahra Tabatabaei, Yuandou Wang, Adrián Colomer, Javier Oliver Moll, Zhiming Zhao, Valery Naranjo
The study shows that the FedCBMIR method increases the F1-Score (F1S) of each client to 98%, 96%, 94%, and 97% in the BreaKHis experiment with a generalized model of four magnifications and does so in 6. 30 hours less time than total local training.
no code implementations • 23 Nov 2021 • Gabriel García, Adrián Colomer, Rafael Verdú-Monedero, José Dolz, Valery Naranjo
Particularly, the proposed two-step learning methodology resorts to pseudo-labels generated during the first step to augment the training dataset on the target domain, which is then used to train the final target model.
no code implementations • 25 Jun 2021 • Gabriel García, Rocío del Amor, Adrián Colomer, Rafael Verdú-Monedero, Juan Morales-Sánchez, Valery Naranjo
Glaucoma is one of the leading causes of blindness worldwide and Optical Coherence Tomography (OCT) is the quintessential imaging technique for its detection.
no code implementations • 25 Jun 2021 • Gabriel García, Anna Esteve, Adrián Colomer, David Ramos, Valery Naranjo
Recently, bladder cancer has been significantly increased in terms of incidence and mortality.
1 code implementation • 21 May 2021 • Julio Silva-Rodríguez, Adrián Colomer, María A. Sales, Rafael Molina, Valery Naranjo
The objective of the work presented in this paper is to develop a deep-learning-based system able to support pathologists in the daily analysis of prostate biopsies.
1 code implementation • 21 May 2021 • Julio Silva-Rodríguez, Adrián Colomer, Valery Naranjo
Regarding the estimation of the core-level Gleason score, we obtained a k of 0. 76 and 0. 67 between the model and two different pathologists.
1 code implementation • 21 May 2021 • Julio Silva-Rodríguez, Adrián Colomer, Jose Dolz, Valery Naranjo
Particularly, the proposed model brings an average improvement on the Cohen's quadratic kappa (k) score of nearly 18% compared to full-supervision for the patch-level Gleason grading task.
no code implementations • 21 May 2021 • Julio Silva-Rodríguez, Elena Payá-Bosch, Gabriel García, Adrián Colomer, Valery Naranjo
Prostate cancer is one of the most prevalent cancers worldwide.
no code implementations • 20 Apr 2021 • Rocío del Amor, Laëtitia Launet, Adrián Colomer, Anaïs Moscardó, Andrés Mosquera-Zamudio, Carlos Monteagudo, Valery Naranjo
Nevertheless, no automatic CAD systems have yet been proposed for the analysis of spitzoid lesions.
no code implementations • 9 Sep 2020 • Gabriel García, Adrián Colomer, Valery Naranjo
Taking into account that glaucoma is the leading cause of blindness worldwide, we propose in this paper three different learning methodologies for glaucoma detection in order to elucidate that traditional machine-learning techniques could outperform deep-learning algorithms, especially when the image data set is small.
no code implementations • 29 May 2020 • Gabriel García, Rocío del Amor, Adrián Colomer, Valery Naranjo
Nowadays, glaucoma is the leading cause of blindness worldwide.
1 code implementation • 22 May 2020 • Amartya Kalapahar, Julio Silva-Rodríguez, Adrián Colomer, Fernando López-Mir, Valery Naranjo
Worldwide, prostate cancer is one of the main cancers affecting men.